MabVax Therapeutics Holdings Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
2,229.00
1,477.10
4,084.10
3,979.30
885.70
Total Accounts Receivable
-
84.30
757.60
-
-
Other Current Assets
381.00
349.30
467.30
314.70
321.80
Total Current Assets
2,610.00
1,910.80
5,309.00
4,294.00
1,207.50
Net Property, Plant & Equipment
-
57.10
135.50
731.70
578.20
Total Investments and Advances
-
-
11.00
-
-
Intangible Assets
-
6,826.00
6,826.00
6,826.00
6,826.00
Other Assets
-
11.00
115.60
168.60
178.60
Total Assets
2,610.00
8,804.90
12,397.10
12,020.30
8,790.30
ST Debt & Current Portion LT Debt
-
-
-
1,606.70
1,699.70
Accounts Payable
-
1,313.20
3,002.50
1,137.90
1,090.90
Other Current Liabilities
955.00
1,652.90
1,955.90
2,946.10
3,015.70
Total Current Liabilities
955.00
2,966.10
4,958.40
5,690.60
5,806.30
Long-Term Debt
-
-
-
2,842.70
1,667.30
Other Liabilities
-
-
-
144.40
186.30
Total Liabilities
955.00
2,966.10
4,958.40
8,677.80
7,659.90
Common Equity (Total)
1,655.00
29.80
7,436.50
3,334.20
1,120.50
Total Shareholders' Equity
1,655.00
5,838.70
7,438.80
3,342.50
1,130.40
Total Equity
1,655.00
5,838.70
7,438.80
3,342.50
1,130.40
Liabilities & Shareholders' Equity
2,610.00
8,804.90
12,397.10
12,020.30
8,790.30
Preferred Stock (Carrying Value)
-
5,868.60
2.20
8.30
10.00
About MabVax Therapeutics Holdings
View Profile
